To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of the Trexima versus placebo as assessed by pain relief and the
incidences of photophobia, phonophobia and nausea at 2 hours after treatment as the primary
endpoints.